Q32 Bio Inc. Common Stock (QTTB) Stock Price

QTTBStock

$16.32+756.54%52W

Market Cap$485.84M

P/E15.71x

PEG Ratio—

Div yield—

Beta0.31

QTTB Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)292.70%

Price vs S&P 500 (4W)1.09%

VGM Score78.11

P/E Ratio (Annual)15.71x

Book Value / Share (Quarterly)$4.46

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)155.81%

Cash Flow / Share (Quarterly)$-0.84

Price vs S&P 500 (YTD)380.81%

Net Profit Margin (TTM)107.43%

EPS (TTM)$2.29

10-Day Avg Trading Volume0.37M

EPS Excl Extra (TTM)$2.29

Revenue Growth (5Y)81.88%

EPS (Annual)$2.42

ROI (Annual)-255.53%

Net Profit Margin (5Y Avg)-2984.10%

Cash / Share (Quarterly)$4.48

P/E Basic Excl Extra (TTM)15.71x

P/E Normalized (Annual)15.71x

ROA (Last FY)-51.88%

EBITD / Share (TTM)$1.27

ROE (5Y Avg)-224.01%

Operating Margin (TTM)85.38%

Cash Flow / Share (Annual)$-5.65

P/B Ratio4.42x

P/B Ratio (Quarterly)2.04x

Net Income / Employee (Annual)$1,242,500

ROA (TTM)45.06%

EV / EBITDA (TTM)23.09x

EPS Incl Extra (Annual)$2.42

Current Ratio (Annual)5.13x

Quick Ratio (Quarterly)19.80x

3-Month Avg Trading Volume1.16M

52-Week Price Return756.54%

P/E Incl Extra (TTM)15.71x

Revenue / Employee (TTM)$2,239,000

P/S Ratio (Annual)8.72x

Asset Turnover (Annual)0.01x

52-Week High$23.57

Operating Margin (5Y Avg)-2631.48%

EPS Excl Extra (Annual)$2.42

CapEx CAGR (5Y)-67.85%

26-Week Price Return303.95%

Quick Ratio (Annual)4.92x

13-Week Price Return197.45%

Total Debt / Equity (Annual)2.29x

Current Ratio (Quarterly)20.30x

Enterprise Value$362.30M

Revenue / Share Growth (5Y)136.64%

Asset Turnover (TTM)0.87x

Revenue / Employee (Annual)$2,239,000

Pretax Margin (Annual)55.49%

Cash / Share (Annual)$6.50

3-Month Return Std Dev261.33%

Net Income / Employee (TTM)$1,242,500

ROE (Last FY)-840.37%

EPS Basic Excl Extra (Annual)$2.42

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$2.29

ROI (TTM)111.62%

P/S Ratio (TTM)8.72x

Pretax Margin (5Y Avg)-2497.64%

Revenue / Share (Annual)$4.36

Price vs S&P 500 (52W)738.23%

P/E Ratio (TTM)15.71x

Year-to-Date Return392.77%

5-Day Price Return7.00%

EPS Normalized (Annual)$2.42

ROA (5Y Avg)-56.34%

Net Profit Margin (Annual)55.49%

Month-to-Date Return4.34%

EBITD / Share (Annual)$1.27

Operating Margin (Annual)28.48%

ROI (5Y Avg)-107.04%

P/E Excl Extra (TTM)15.71x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$2.29

P/B Ratio (Annual)8.38x

Pretax Margin (TTM)107.43%

Book Value / Share (Annual)$0.42

Price vs S&P 500 (13W)194.66%

Beta0.31x

P/FCF (Annual)103.67x

Revenue / Share (TTM)$4.26

ROE (TTM)137.41%

52-Week Low$1.62

vGradeC

gGradeA

mGradeA

vgmGradeB

QTTB Earnings Surprise History

Q2 25-0.78est. -0.98

Q3 25-0.60est. -1.19

Q4 254.58est. -0.86

Q1 26-0.54est. -0.68

Q2 26-0.44est. -0.54

QTTB Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.11

4.09

4.18

Industry Peers — Pharmaceuticals(571)

Symbol	Value Score	Growth Score	Momentum Score	Price
QTTBQ32 Bio Inc. Common Stock	C	A	A	$16.32
LLYEli Lilly & Co.	D	B	B	$1233.66
JNJJohnson & Johnson	D	C	B	$273.14
ABBVABBVIE INC.	D	C	B	$265.79
MRKMerck & Co., Inc.	D	C	A	$156.45
NVSNovartis AG	C	C	C	$159.98
AZNAstraZeneca PLC	C	B	C	$169.66
NVONovo-Nordisk A/S	B	C	C	$48.66
ABTAbbott Laboratories	C	C	B	$116.13
PFEPfizer Inc.	C	D	C	$28.57
VRTXVertex Pharmaceuticals Inc	D	C	B	$552.85
BMYBristol-Myers Squibb Co.	B	B	B	$67.92
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$46.02
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$52.07
REGNRegeneron Pharmaceuticals Inc	C	C	B	$833.56
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	C	$18.35
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$38.10
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	C	$376.37
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$62.07
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$240.08
ZTSZOETIS INC.	B	C	D	$77.29
INSMInsmed, Inc.	F	A	C	$123.89
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$36.47
UTHRUnited Therapeutics Corp	C	C	C	$518.53
GMABGenmab A/S ADS	C	C	B	$34.36
VTRSViatris Inc. Common Stock	B	C	B	$16.72
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$260.23
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$252.99
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$80.40
CORTCorcept Therapeutics Inc.	F	C	A	$123.57
BMRNBioMarin Pharmaceuticals Inc	C	C	C	$66.12
ARWRArrowhead Research Corporation	D	A	B	$88.88
ELANElanco Animal Health Incorporated Common Stock	C	B	B	$25.09
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	C	$512.16
CYTKCytokinetics Inc.	F	D	B	$77.46
AXSMAxsome Therapeutics, Inc	D	B	C	$205.48
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.36
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$63.57
ABVXAbivax SA American Depositary Shares	—	—	C	$117.93
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.34
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$368.02
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
PTGXProtagonist Therapeutics, Inc	F	B	A	$150.59
SYRESpyre Therapeutics, Inc. Common Stock	—	—	A	$107.36
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.86
TGTXTG Therapeutics, Inc.	D	B	A	$55.42
ALKSAlkermes Inc. plc	D	C	B	$49.21
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$113.35
ORKAOruka Therapeutics, Inc. Common Stock	F	—	A	$101.82
BLTEBelite Bio, Inc American Depositary Shares	—	—	B	$161.68
COGTCogent Biosciences, Inc. Common Stock	F	—	B	$36.80

About Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company developing antibody-based therapeutics for autoimmune and inflammatory diseases. The company targets key pathways in both adaptive immunity (T and B cells) and innate immunity to restore immune balance. Q32's approach is designed to provide safe and effective treatment options for patients with pathological immune dysfunction.